Terms: = Lymphoma AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Clinical Outcome
185 results:
1. Validation of genes for H-ARS severity prediction in leukemia patients - interspecies comparison, challenges, and promises.
Schwanke D; Valente M; Ostheim P; Schüle S; Bobyk L; Drouet M; Riccobono D; Magné N; Daguenet E; Stewart SJ; Muhtadi R; Port M; Abend M
Int J Radiat Biol; 2024; 100(4):527-540. PubMed ID: 38227483
[TBL] [Abstract] [Full Text] [Related]
2. The biological role of lncRNAs in the acute lymphocytic leukemia: An updated review.
Ghahramani Almanghadim H; Karimi B; Poursalehi N; Sanavandi M; Atefi Pourfardin S; Ghaedi K
Gene; 2024 Mar; 898():148074. PubMed ID: 38104953
[TBL] [Abstract] [Full Text] [Related]
3. Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia.
Kumar A; Taghi Khani A; Duault C; Aramburo S; Sanchez Ortiz A; Lee SJ; Chan A; McDonald T; Huang M; Lacayo NJ; Sakamoto KM; Yu J; Hurtz C; Carroll M; Tasian SK; Ghoda L; Marcucci G; Gu Z; Rosen ST; Armenian S; Izraeli S; Chen CW; Caligiuri MA; Forman SJ; Maecker HT; Swaminathan S
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37217248
[TBL] [Abstract] [Full Text] [Related]
4. Serpin B9 controls tumor cell killing by CAR T cells.
Kimman T; Slomp A; Martens A; Grabherr S; Li S; van Diest E; Meeldijk J; Kuball J; Minnema MC; Eldering E; Bovenschen N; Sebestyén Z; Peperzak V
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36931661
[TBL] [Abstract] [Full Text] [Related]
5. Bcl-2 Family Members Bcl-xL and Bax Cooperatively Contribute to Bortezomib Resistance in Mantle Cell lymphoma.
Luanpitpong S; Janan M; Yosudjai J; Poohadsuan J; Chanvorachote P; Issaragrisil S
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430955
[TBL] [Abstract] [Full Text] [Related]
6. Association of Human Papillomavirus and Epstein-Barr Virus Infection with Tonsil Cancer in Northeastern Thailand.
Heawchaiyaphum C; Ekalaksananan T; Patarapadungkit N; Vatanasapt P; Pientong C
Asian Pac J Cancer Prev; 2022 Mar; 23(3):781-787. PubMed ID: 35345347
[TBL] [Abstract] [Full Text] [Related]
7. Serum TK1 protein and C-reactive protein correlate to treatment response and predict survival in dogs with hematologic malignancies.
Saellström S; Sharif H; Jagarlamudi KK; Rönnberg H; Wang L; Eriksson S
Res Vet Sci; 2022 Jul; 145():213-221. PubMed ID: 35245727
[TBL] [Abstract] [Full Text] [Related]
8. HELICOBACTER PYLORI cagA VIRULENCE GENE AND SEVERE ESOGASTRODUODENAL DISEASES: IS THERE AN ASSOCIATION?
Oliveira AKS; Silva LLL; Miguel MP; Blanco AJV; Carneiro LC; Barbosa MS
Arq Gastroenterol; 2021; 58(4):468-475. PubMed ID: 34909852
[TBL] [Abstract] [Full Text] [Related]
9. RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia.
Masuda T; Maeda S; Shimada S; Sakuramoto N; Morita K; Koyama A; Suzuki K; Mitsuda Y; Matsuo H; Kubota H; Kato I; Tanaka K; Takita J; Hirata M; Kataoka TR; Nakahata T; Adachi S; Hirai H; Mizuta S; Naka K; Imai Y; Kimura S; Sugiyama H; Kamikubo Y
Cancer Sci; 2022 Feb; 113(2):529-539. PubMed ID: 34902205
[TBL] [Abstract] [Full Text] [Related]
10. Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived lymphoma Phenotypes and outcomes.
Rivas MA; Durmaz C; Kloetgen A; Chin CR; Chen Z; Bhinder B; Koren A; Viny AD; Scharer CD; Boss JM; Elemento O; Mason CE; Melnick AM
Front Immunol; 2021; 12():688493. PubMed ID: 34621263
[TBL] [Abstract] [Full Text] [Related]
11. The antibody drug conjugate VLS-101 targeting ROR1 is effective in CAR T-resistant mantle cell lymphoma.
Jiang VC; Liu Y; Jordan A; McIntosh J; Li Y; Che Y; Jessen KA; Lannutti BJ; Wang M
J Hematol Oncol; 2021 Aug; 14(1):132. PubMed ID: 34454548
[TBL] [Abstract] [Full Text] [Related]
12. A proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma.
Zhou N; Xu X; Liu Y; Wang Y; Wei W
Eye (Lond); 2022 Jul; 36(7):1448-1455. PubMed ID: 34211136
[TBL] [Abstract] [Full Text] [Related]
13. A Case of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm Treated With a Bcl-2 Inhibitor.
Egger A; Coello D; Kirsner RS; Brehm JE
J Drugs Dermatol; 2021 May; 20(5):550-551. PubMed ID: 33938687
[TBL] [Abstract] [Full Text] [Related]
14. Expression levels of HLA-DR in acute myeloid leukemia: implications for antigenicity and clinical outcome.
Roerden M; Märklin M; Salih HR; Bethge WA; Klein R; Rammensee HG; Nelde A; Walz JS
Leuk Lymphoma; 2021 Aug; 62(8):1907-1919. PubMed ID: 33648413
[TBL] [Abstract] [Full Text] [Related]
15. Macrophages in dermatology: pathogenic roles and targeted therapeutics.
Kuraitis D; Rosenthal N; Boh E; McBurney E
Arch Dermatol Res; 2022 Mar; 314(2):133-140. PubMed ID: 33641015
[TBL] [Abstract] [Full Text] [Related]
16. [Pharmacokinetics and pharmacodynamics of pegylated recombinant human granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia: a prospective control trial].
Yang WY; Liu TF; Chen XJ; Guo Y; Li T; Qi BQ; Liu F; Chang LX; Ruan M; Liu XM; Zhang L; Zou Y; Chen YM; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Nov; 22(11):1172-1177. PubMed ID: 33172550
[TBL] [Abstract] [Full Text] [Related]
17. Telomere Length and Hematological Disorders: A Review.
Nogueira BMD; Machado CB; Montenegro RC; DE Moraes MEA; Moreira-Nunes CA
In Vivo; 2020; 34(6):3093-3101. PubMed ID: 33144412
[TBL] [Abstract] [Full Text] [Related]
18. [
Yan JH; Luo DL; Zhang F; Chen Y; Luo XL; Xu J; Li Z; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2020 Oct; 49(10):1027-1030. PubMed ID: 32992417
[No Abstract] [Full Text] [Related]
19. Exhaustion of tumour-infiltrating T-cell receptor repertoire diversity is an age-dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphoma.
Rieken J; Bernard V; Witte HM; Peter W; Merz H; Olschewski V; Hertel L; Lehnert H; Biersack H; von Bubnoff N; Feller AC; Gebauer N
Br J Haematol; 2021 Apr; 193(1):138-149. PubMed ID: 32945554
[TBL] [Abstract] [Full Text] [Related]
20. IKKε and TBK1 in diffuse large B-cell lymphoma: A possible mechanism of action of an IKKε/TBK1 inhibitor to repress NF-κB and IL-10 signalling.
Carr M; Mamand S; Chapman KL; Perrior T; Wagner SD
J Cell Mol Med; 2020 Oct; 24(19):11573-11582. PubMed ID: 32858764
[TBL] [Abstract] [Full Text] [Related]
[Next]
